RGM Capital LLC grew its position in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 12.8% in the first quarter, according to its most recent filing with the SEC. The fund owned 1,489,791 shares of the company's stock after acquiring an additional 169,200 shares during the quarter. Revvity comprises approximately 6.5% of RGM Capital LLC's holdings, making the stock its 6th largest holding. RGM Capital LLC owned 1.26% of Revvity worth $157,620,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Nomura Holdings Inc. bought a new position in shares of Revvity during the 4th quarter valued at approximately $447,000. Wealth Enhancement Advisory Services LLC lifted its position in Revvity by 3.8% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 5,139 shares of the company's stock worth $544,000 after buying an additional 187 shares during the last quarter. Ritholtz Wealth Management bought a new stake in Revvity in the first quarter worth $210,000. Amalgamated Bank lifted its position in Revvity by 1.0% in the first quarter. Amalgamated Bank now owns 23,777 shares of the company's stock worth $2,516,000 after buying an additional 227 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. lifted its position in Revvity by 11.1% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 13,415 shares of the company's stock worth $1,417,000 after buying an additional 1,343 shares during the last quarter. 86.65% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
RVTY has been the subject of a number of analyst reports. Raymond James Financial restated an "outperform" rating and issued a $115.00 price target (down from $120.00) on shares of Revvity in a research report on Tuesday, July 29th. Wall Street Zen downgraded Revvity from a "buy" rating to a "hold" rating in a research report on Sunday, August 3rd. Evercore ISI lowered their price target on Revvity from $116.00 to $115.00 and set an "outperform" rating for the company in a research report on Tuesday, July 8th. Stifel Nicolaus lowered their price target on Revvity from $120.00 to $110.00 and set a "hold" rating for the company in a research report on Tuesday, July 29th. Finally, Bank of America lowered their price target on Revvity from $116.00 to $110.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. Ten equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $120.07.
Read Our Latest Research Report on Revvity
Revvity Trading Up 1.1%
RVTY stock traded up $0.98 during midday trading on Friday, reaching $90.21. The company's stock had a trading volume of 786,177 shares, compared to its average volume of 1,133,210. The firm has a market capitalization of $10.47 billion, a price-to-earnings ratio of 38.23, a PEG ratio of 2.42 and a beta of 0.91. The company has a debt-to-equity ratio of 0.43, a quick ratio of 2.75 and a current ratio of 3.33. Revvity Inc. has a 1 year low of $85.12 and a 1 year high of $129.50. The stock has a fifty day simple moving average of $94.11 and a two-hundred day simple moving average of $98.02.
Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings results on Monday, July 28th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.14 by $0.04. The firm had revenue of $720.28 million for the quarter, compared to analyst estimates of $711.26 million. Revvity had a return on equity of 7.66% and a net margin of 10.19%.The business's revenue for the quarter was up 4.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.22 earnings per share. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. On average, equities research analysts predict that Revvity Inc. will post 4.94 EPS for the current year.
Revvity Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 17th will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, October 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity's dividend payout ratio (DPR) is currently 11.86%.
About Revvity
(
Free Report)
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Recommended Stories

Before you consider Revvity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.
While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.